Breaking

Nawrocki wins Polish presidency with 50.89% vote; signals shift in EU ties
Constellium CEO warns 50% aluminum tariff hike could backfire
Brazil’s Cemig shares hold ground as bullish momentum persists despite minor setback
Bitcoin Pepe announces new listing date and 30% bonus for early buyers
Bristol Myers CEO explains why he’s spending billions on BioNTech deal
Singapore’s cross-border interconnections set to unlock 25 GW of new renewable capacity, says Rystad
Vietnam firms to sign $2B deal for US agricultural products
No easy way out: OECD warns Trump’s tariffs are choking global growth, fueling inflation

Business
Investing
Stocks
World
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Allied Critical Metals Commences 5,000 Metre Drill Program at its Borralha Tungsten Project

Development update – Collie graphite micronising facility

Top 10 Uranium-producing Countries

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (41)
- Investing (176)
- Stocks (194)
- World (215)

Disclaimer: perfectdaytrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 perfectdaytrading.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.